As AI has evolved to be more accurate and reliable, it’s become suitable for high-stakes use cases including automating health insurance verification. The post The Patient Intake Revolution – How AI Is Eliminating Intake Busywork and Reducing Insurance Denials appeared first on MedCity News.
In a webinar sponsored by Personify Health, executives from international chemical company Dow and the National Alliance of Healthcare Purchaser Coalitions discussed some of the tough choices companies are making. The post How Can Self-Insured Employers Identify Ways to Rein in Healthcare Costs? appeared first on MedCity News.
The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by driving up the cost of essential supplies and exacerbating already fragile supply chains. As providers prepare for higher expenses and potential shortages, experts warn that these policies could wosen care quality and force hospitals to make tough financial…
Janice Walters, executive director of the Rural Health Care Redesign Center, recently discussed working with rural hospitals under a global budget in Pennsylvania
This interactive map shows the increase in states with laws restricting abortion coverage in Medicaid and private insurance since 2010.
Gilead Sciences’ Trodelvy did not meet the main overall survival goal of its confirmatory Phase 3 test. The antibody drug conjugate was awarded accelerated approval for advanced urothelial carcinoma in 2021. The post Gilead Sciences Voluntarily Pulls Drug for Bladder Cancer After Trial Failure appeared first on MedCity News.
LISTEN: KFF Health News correspondent Rachana Pradhan spoke with federal employees who say mass government layoffs are affecting their mental health. She appeared on WAMU’s “Health Hub” segment on April 2. Federal workers are feeling demoralized and anxious as the Department of Government Efficiency slashes tens of thousands of jobs. Federal employment used to carry…
By SAURABH JHA Early on in the COVID-19 pandemic a seroprevalence study from Santa Clara indicated that the viral spread was far greater than was believed. The study suggested that the infection fatality rate (IFR) was much lower than the case fatality rate and perhaps even lower than the suspected IFR. The researchers estimated that…
Abeona Therapeutics makes Zevaskyn by engineering a patient’s biopsied skin cells to express the collagen that they lack, then growing those cells into sheets that can be surgically applied to a wound. Abeona’s cell-based gene therapy is just the third FDA-approved treatment for epidermolysis bullosa, a rare disease that leads to skin described as thin…
by MIKE MAGEE THCB is back from its end of year break, but we are starting with a little catchup from December from Mike Magee. As my wife often reminds me, “Comparisons are toxic.” And, in general, I agree and try to respect this cardinal rule. But these are extraordinary times. So grant me this…